Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Buy
59
JDOC Quote, Financials, Valuation and Earnings
Last price:
$58.01
Seasonality move
:
6.5%
Day range:
$58.01 - $58.44
52-week range:
$47.67 - $59.45
Dividend yield:
4.86%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
1.2K
Avg. volume:
1.1K
1-year change:
1.94%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- |
|
HRTS
Tema Heart & Health ETF
|
-- | -- | -- | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
JDOC
JPMorgan Healthcare Leaders ETF
|
$58.01 | -- | -- | -- | $0.33 | 4.86% | -- |
|
AGNG
Global X Aging Population ETF
|
$36.31 | -- | -- | -- | $0.14 | 0.79% | -- |
|
BMED
iShares Health Innovation Active ETF
|
$30.51 | -- | -- | -- | $0.01 | 0% | -- |
|
HRTS
Tema Heart & Health ETF
|
$35.35 | -- | -- | -- | $0.47 | 0.4% | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
$25.22 | -- | -- | -- | $0.22 | 0.87% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | 0.523 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 0.484 | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | 0.918 | -- | -- |
|
HRTS
Tema Heart & Health ETF
|
-- | 0.753 | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | 0.787 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
JDOC
JPMorgan Healthcare Leaders ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
BMED
iShares Health Innovation Active ETF
|
-- | -- | -- | -- | -- | -- |
|
HRTS
Tema Heart & Health ETF
|
-- | -- | -- | -- | -- | -- |
|
THNR
Amplify Weight Loss Drug & Treatment ETF
|
-- | -- | -- | -- | -- | -- |
JPMorgan Healthcare Leaders ETF vs. Competitors
-
Which has Higher Returns JDOC or AGNG?
Global X Aging Population ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About JDOC or AGNG?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than Global X Aging Population ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is JDOC or AGNG More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.743, suggesting its less volatile than the S&P 500 by 25.722%.
-
Which is a Better Dividend Stock JDOC or AGNG?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 4.86%. Global X Aging Population ETF offers a yield of 0.79% to investors and pays a quarterly dividend of $0.14 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or AGNG?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns JDOC or BMED?
iShares Health Innovation Active ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat iShares Health Innovation Active ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- BMEDiShares Health Innovation Active ETF-- -- -- -
What do Analysts Say About JDOC or BMED?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand iShares Health Innovation Active ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than iShares Health Innovation Active ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than iShares Health Innovation Active ETF.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 BMEDiShares Health Innovation Active ETF0 0 0 -
Is JDOC or BMED More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison iShares Health Innovation Active ETF has a beta of 0.901, suggesting its less volatile than the S&P 500 by 9.904%.
-
Which is a Better Dividend Stock JDOC or BMED?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 4.86%. iShares Health Innovation Active ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.01 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. iShares Health Innovation Active ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or BMED?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than iShares Health Innovation Active ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than iShares Health Innovation Active ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while iShares Health Innovation Active ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for iShares Health Innovation Active ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- BMEDiShares Health Innovation Active ETF-- -- -- --
-
Which has Higher Returns JDOC or HRTS?
Tema Heart & Health ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat Tema Heart & Health ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- HRTSTema Heart & Health ETF-- -- -- -
What do Analysts Say About JDOC or HRTS?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema Heart & Health ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than Tema Heart & Health ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than Tema Heart & Health ETF.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 HRTSTema Heart & Health ETF0 0 0 -
Is JDOC or HRTS More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tema Heart & Health ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock JDOC or HRTS?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 4.86%. Tema Heart & Health ETF offers a yield of 0.4% to investors and pays a quarterly dividend of $0.47 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. Tema Heart & Health ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or HRTS?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than Tema Heart & Health ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than Tema Heart & Health ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while Tema Heart & Health ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for Tema Heart & Health ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- HRTSTema Heart & Health ETF-- -- -- --
-
Which has Higher Returns JDOC or THNR?
Amplify Weight Loss Drug & Treatment ETF has a net margin of -- compared to JPMorgan Healthcare Leaders ETF's net margin of --. JPMorgan Healthcare Leaders ETF's return on equity of -- beat Amplify Weight Loss Drug & Treatment ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital JDOCJPMorgan Healthcare Leaders ETF-- -- -- THNRAmplify Weight Loss Drug & Treatment ETF-- -- -- -
What do Analysts Say About JDOC or THNR?
JPMorgan Healthcare Leaders ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Amplify Weight Loss Drug & Treatment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that JPMorgan Healthcare Leaders ETF has higher upside potential than Amplify Weight Loss Drug & Treatment ETF, analysts believe JPMorgan Healthcare Leaders ETF is more attractive than Amplify Weight Loss Drug & Treatment ETF.
Company Buy Ratings Hold Ratings Sell Ratings JDOCJPMorgan Healthcare Leaders ETF0 0 0 THNRAmplify Weight Loss Drug & Treatment ETF0 0 0 -
Is JDOC or THNR More Risky?
JPMorgan Healthcare Leaders ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Amplify Weight Loss Drug & Treatment ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock JDOC or THNR?
JPMorgan Healthcare Leaders ETF has a quarterly dividend of $0.33 per share corresponding to a yield of 4.86%. Amplify Weight Loss Drug & Treatment ETF offers a yield of 0.87% to investors and pays a quarterly dividend of $0.22 per share. JPMorgan Healthcare Leaders ETF pays -- of its earnings as a dividend. Amplify Weight Loss Drug & Treatment ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios JDOC or THNR?
JPMorgan Healthcare Leaders ETF quarterly revenues are --, which are smaller than Amplify Weight Loss Drug & Treatment ETF quarterly revenues of --. JPMorgan Healthcare Leaders ETF's net income of -- is lower than Amplify Weight Loss Drug & Treatment ETF's net income of --. Notably, JPMorgan Healthcare Leaders ETF's price-to-earnings ratio is -- while Amplify Weight Loss Drug & Treatment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for JPMorgan Healthcare Leaders ETF is -- versus -- for Amplify Weight Loss Drug & Treatment ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income JDOCJPMorgan Healthcare Leaders ETF-- -- -- -- THNRAmplify Weight Loss Drug & Treatment ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Sell
50
TGL alert for Dec 8
Treasure Global, Inc. [TGL] is up 3.46% over the past day.
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 47.95% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 10.69% over the past day.
